New Drug
Application (NDA): The application process whereby an
agency such as a pharmaceutical
manufacturer gains FDA
approval to sell a new drug.
Generally the final step in bringing a new drug
to market, completed after the Investigational
New Drug (NDA)
and clinical
trial phases of drug
development.
A 1930's sulfapyridine
NDA. Modern NDAs are much more complex documents.
